患者选择与医院竞争对肿瘤手术服务配置和技术采用的影响
结果显示竞争较强地区的中心更易关闭,已开展机器人手术的中心无论患者净流失多少均未关闭,开展机器人手术的中心由12/65增至39/55。
要点
- 65家中心中23家(35%)患者净增加,37家(57%)净减少,10家(27%)关闭前列腺癌根治术服务。
- 关闭的中心更可能位于竞争较强地区(最高SCI四分位0·87-0·92;p=0·0081)。
- 开展机器人手术的中心由2010年初12家(18%)增至2014年末39家(71%)。
核心结论
- 竞争因素与集中化政策及最低手术量要求共同促使机器人手术设备大规模投入,但无证据显示结局更优,并促成肿瘤手术单元关闭。
- 若缺乏质量绩效和结局指标引导患者选择,这些政策可能威胁卫生服务提供公平且可负担的肿瘤诊疗的能力。
研究设计与样本
- 全国性、基于人群的研究,使用英格兰NHS 2010年1月1日至2014年12月31日接受前列腺癌根治术的全部患者,按居住地和治疗地点映射。
- 对每家前列腺癌根治术中心分析医院竞争(空间竞争指数SCI,0为竞争最弱,1为最强)及2010年初是否为已建成的机器人前列腺癌根治术中心对患者净增减和关闭服务可能性的影响。
主要发现
- 研究期初开业的65家中心中23家(35%)在2010-14年有统计学显著的患者净增加,其中10家(40%)为已建成的机器人中心。
- 65家中心中37家(57%)有显著患者净减少,其中2家(5%)为已建成的机器人中心,10家(27%)在研究期间关闭了前列腺癌根治术服务。
- 关闭的中心更可能位于竞争较强地区(最高SCI四分位[0·87-0·92];p=0·0081)而非竞争较弱地区。
- 无论患者净流失规模大小,没有机器人手术中心关闭;开展机器人手术的中心从2010年初65家中的12家(18%)增至2014年末开业55家中的39家(71%)。
临床怎么用
- 结果提示患者流动与医院竞争可影响肿瘤手术服务的存续与技术采用,需结合质量绩效和结局指标引导患者选择。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There is a scarcity of evidence about the role of patient choice and hospital competition policies on surgical cancer services. Previous evidence has shown that patients are prepared to bypass their nearest cancer centre to receive surgery at more distant centres that better meet their needs. In this national, population-based study we investigated the effect of patient mobility and hospital competition on service configuration and technology adoption in the National Health Service (NHS) in England, using prostate cancer surgery as a model. METHODS: We mapped all patients in England who underwent radical prostatectomy between Jan 1, 2010, and Dec 31, 2014, according to place of residence and treatment location. For each radical prostatectomy centre we analysed the effect of hospital competition (measured by use of a spatial competition index [SCI], with a score of 0 indicating weakest competition and 1 indicating strongest competition) and the effect of being an established robotic radical prostatectomy centre at the start of 2010 on net gains or losses of patients (difference between number of patients treated in a centre and number expected based on their residence), and the likelihood of closing their radical prostatectomy service. FINDINGS: Between Jan 1, 2010, and Dec 31, 2014, 19 256 patients underwent radical prostatectomy at an NHS provider in England. Of the 65 radical prostatectomy centres open at the start of the study period, 23 (35%) had a statistically significant net gain of patients during 2010-14. Ten (40%) of these 23 were established robotic centres. 37 (57%) of the 65 centres had a significant net loss of patients, of which two (5%) were established robotic centres and ten (27%) closed their radical prostatectomy service during the study period. Radical prostatectomy centres that closed were more likely to be located in areas with stronger competition (highest SCI quartile [0·87-0·92]; p=0·0081) than in areas with weaker competition. No robotic surgery centre closed irrespective of the size of net losses of patients. The number of centres performing robotic surgery increased from 12 (18%) of the 65 centres at the beginning of 2010 to 39 (71%) of 55 centres open at the end of 2014. INTERPRETATION: Competitive factors, in addition to policies advocating centralisation and the requirement to do minimum numbers of surgical procedures, have contributed to large-scale investment in equipment for robotic surgery without evidence of superior outcomes and contributed to the closure of cancer surgery units. If quality performance and outcome indicators are not available to guide patient choice, these policies could threaten health services' ability to deliver equitable and affordable cancer care. FUNDING: National Institute for Health Research.
引用
- Aggarwal A, Lewis D, Mason M, et al. Effect of patient choice and hospital competition on service configuration and technology adoption within cancer surgery: a national, population-based study. Lancet Oncol. 2017. PMID: 28986012. doi:10.1016/S1470-2045(17)30572-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。